Related Experiment Video
Updated: Jan 22, 2026

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
TET1 as a master regulator controlling GPX4-dependent and -independent ferroptosis surveillance in acute myeloid
Lingling Yang1,2,3, Jun Lu1,2,3, Weina Yun1,2,3
1Department of Pharmacology, Bone Marrow Transplantation Center of the First Affiliated Hospital, Zhejiang University School of Medicine, and Zhejiang Key Laboratory of Medical Epigenetics, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Hangzhou Normal University, Hangzhou, Zhejiang, China.
Abstract:
Ferroptosis, an iron-dependent, lipid peroxidation-driven programmed cell death, holds substantial promise for cancer therapy, yet its translational potential is hindered by widespread intrinsic resistance. While glutathione peroxidase 4 (GPX4) is a well-established ferroptosis suppressor, the epigenetic circuitry coordinating GPX4-related mechanisms remains elusive. Here, via genome-wide screening, we identify ten-eleven translocation 1 (TET1)-a key mediator of DNA 5-hydroxymethylation-as a master controller of cancer cell ferroptosis susceptibility. In acute myeloid leukemia (AML), TET1 enhances 5hmC deposition at the glutamate-cysteine ligase catalytic subunit (GCLC) promoter to activate glutathione/γ-glutamyl-peptide metabolism, fortifying GPX4-dependent defense. Concurrently, TET1 activates NFκB signaling to upregulate GTP cyclohydrolase-1 (GCH1), conferring GPX4-independent ferroptosis resistance. Critically, co-targeting TET1/GCLC/GCH1 with low-dose ferroptosis inducers exhibits potent therapeutic effects against both ferroptosis-sensitive and -resistant AML. Our work positions TET1 as a pivotal epigenetic hub governing ferroptosis surveillance, and provides a translatable strategy to overcome ferroptosis resistance in cancer, with AML as a paradigm.
Insights
Ten-eleven translocation 1 (TET1) epigenetically controls ferroptosis susceptibility in cancer. Targeting TET1, GCLC, and GCH1 overcomes ferroptosis resistance, offering a new strategy for acute myeloid leukemia (AML) therapy.
Area of Science:
- Cancer Biology
- Epigenetics
- Cell Death Mechanisms
Background:
- Ferroptosis, a programmed cell death, is promising for cancer therapy but faces resistance.
- Glutathione peroxidase 4 (GPX4) suppresses ferroptosis, but its regulatory network is unclear.
Purpose of the Study:
- Identify epigenetic regulators of ferroptosis susceptibility.
- Investigate the role of ten-eleven translocation 1 (TET1) in ferroptosis.
- Develop strategies to overcome ferroptosis resistance in cancer, particularly AML.
Main Methods:
- Genome-wide screening to identify ferroptosis regulators.
- Analysis of TET1's role in DNA 5-hydroxymethylation (5hmC) and gene expression.
- Investigating TET1's impact on glutathione/γ-glutamyl-peptide metabolism and NFκB signaling.
- Evaluating therapeutic strategies targeting TET1, GCLC, and GCH1 in AML models.
Main Results:
- TET1 was identified as a key regulator of cancer cell ferroptosis susceptibility.
- TET1 promotes 5hmC deposition at the GCLC promoter, enhancing GPX4-dependent ferroptosis defense.
- TET1 activates NFκB signaling, upregulating GCH1 for GPX4-independent ferroptosis resistance.
- Combined targeting of TET1/GCLC/GCH1 with ferroptosis inducers showed potent effects against AML.
Conclusions:
- TET1 is a critical epigenetic hub controlling ferroptosis surveillance.
- Targeting TET1 offers a translatable strategy to overcome ferroptosis resistance in AML and potentially other cancers.
Related Concept Videos
Master Transcription Regulators
Master Transcription Regulators
Independent and Dependent Sources
Independent voltage or current sources supply a fixed amount of voltage or current, respectively, which is unaffected by other elements within the circuit. These are represented using specific symbols. Independent voltage sources are symbolized with polarities (+ and -), indicating the direction of the...
Introduction to Test of Independence
The test statistic for a test of independence is similar to that of a goodness-of-fit test:
Hypothesis Test for Test of Independence
H0: The two variables (factors)...
Principles of Disease Surveillance

